Literature DB >> 4024633

Managing patients who have myasthenia gravis.

T R Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4024633      PMCID： PMC1306184     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  6 in total

1.  The role of thymectomy in the treatment of myasthenia gravis.

Authors:  V P Perlo; B Arnason; D Poskanzer; B Castleman; R S Schwab; K E Osserman; A Papatestis; L Alpert; A Kark
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

2.  Myasthenia gravis: prolonged treatment with steroids.

Authors:  A Sghirlanzoni; D Peluchetti; R Mantegazza; F Fiacchino; F Cornelio
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

3.  Effect of immunosuppressive drugs (azathioprine).

Authors:  H G Mertens; G Hertel; P Reuther; K Ricker
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.

Authors:  R M Pascuzzi; H B Coslett; T R Johns
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

Review 5.  Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.

Authors:  J A Simpson
Journal:  Muscle Nerve       Date:  1978 Mar-Apr       Impact factor: 3.217

6.  Azathioprine in the treatment of myasthenia gravis.

Authors:  A S Witte; D R Cornblath; G J Parry; R P Lisak; N J Schatz
Journal:  Ann Neurol       Date:  1984-06       Impact factor: 10.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.